Stock Taper
EXCHANGE TRADED FUND

BBH

VanEck Biotech ETF
$236.48 ▼ 2.28%
−$5.51 TODAY

FUND FACTS

Manager VanEck
Assets $469.72M
Expense ratio 0.35%
Inception Dec 20, 2011
Asset class Equity
Holdings 24
Volume 11.6K
Avg volume 5.73K

ABOUT THIS FUND

The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.

PRICE

$236.48 ▼ DOWN 2.28% (−$5.51)
$236$237$239$2409:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM236.48

HOLDINGS

TOP 20 OF 24 · 95.28% OF THE FUND
RANK STOCK WEIGHT SHARES VALUE
01 AMGN Amgen Inc. 15.45% 169.99K $74.29M
02 GILD Gilead Sciences, Inc. 12.65% 408.57K $60.82M
05 MRNA Moderna, Inc. 5.76% 193.86K $27.68M
06 RVMD Revolution Medicines, Inc. 5.23% 113.67K $25.14M
07 NTRA Natera, Inc. 5.15% 73.15K $24.78M
08 IQV IQVIA Holdings Inc. 4.91% 89.97K $23.61M
09 ARGX argenx SE 4.77% 21.63K $22.91M
10 ILMN Illumina, Inc. 3.45% 72.8K $16.58M
11 BIIB Biogen Inc. 3.12% 67.76K $15.01M
12 ONC BeOne Medicines AG 3.08% 39.8K $14.82M
13 INSM Insmed Incorporated 2.55% 101.08K $12.27M
15 INCY Incyte Corporation 2.36% 88.73K $11.33M
17 BNTX BioNTech SE 1.95% 84.24K $9.38M

SECTOR HOLDINGS

TECHNOLOGY IS 100.00% OF THE FUND
Healthcare 100.00%

BY REGION

UNITED STATES IS 87.51% OF THE FUND
United States 87.51%
Netherlands 5.71%
Switzerland 3.11%
Germany 2.05%
Ireland 1.59%
Other 0.03%